Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sildenafil: a new oral therapy for erectile dysfunction.

M B Noss1, G J Christ, A Melman

  • 1Department of Urology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York 10467, USA.

Drugs of Today (Barcelona, Spain : 1998)
|September 16, 2003
PubMed
Summary

Sildenafil citrate, a PDE5 inhibitor, effectively treats erectile dysfunction by increasing cGMP levels for penile erection. This oral medication has revolutionized ED therapy since its FDA approval.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioprinting on sheet-based scaffolds applied to the creation of implantable tissue-engineered constructs with potentially diverse clinical applications: Tissue-Engineered Muscle Repair (TEMR) as a representative testbed.

Connective tissue research·2020
Same author

Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue.

International journal of impotence research·2010
Same author

Premature ejaculation, priapism, and Peyronie's disease.

Postgraduate medicine·2009
Same author

Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat.

Gene therapy·2008
Same author

Ageing causes cytoplasmic retention of MaxiK channels in rat corporal smooth muscle cells.

International journal of impotence research·2007
Same author

Expression of myosin isoforms in the smooth muscle of human corpus cavernosum.

International journal of impotence research·2006

Area of Science:

  • Pharmacology
  • Urology

Background:

  • Erectile dysfunction (ED) is a condition affecting millions of men.
  • Current ED treatments have limitations.
  • Sildenafil citrate emerged as a novel therapeutic agent.

Purpose of the Study:

  • To review the mechanism of action, pharmacokinetics, and clinical impact of sildenafil citrate in treating ED.
  • To highlight sildenafil's role as the first oral therapy for ED.

Main Methods:

  • Review of existing literature on sildenafil citrate.
  • Analysis of its pharmacological properties, including PDE5 inhibition.
  • Examination of clinical trial data and post-marketing surveillance.

Main Results:

  • Sildenafil citrate selectively inhibits phosphodiesterase type 5 (PDE5).

Related Experiment Videos

  • It enhances nitric oxide (NO)-mediated increases in cyclic guanosine monophosphate (cGMP) levels.
  • This leads to corporal smooth muscle relaxation and facilitates penile erection.

    • Conclusions:

    • Sildenafil citrate is an effective and well-tolerated oral treatment for ED.
    • Its approval revolutionized ED management, offering a new therapeutic paradigm.
    • The drug's favorable pharmacokinetic profile supports its clinical utility.